A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)
Takao Namiki(Chiba University), Takashi Ito(Osaka Nishi Clinic), Mosaburo Kainuma(Kyushu University), Hajime Nakae, Tatsuya Nogami(Tokai University), Masaru Mimura(Keio University), Toshiaki Makino(Nagoya City University), Shin Takayama(Tohoku University), Yohei Kawasaki(Japanese Red Cross College of Nursing), Tetsuhiro Yoshino(Keio University Hospital), Yuki Shiko(Chiba University Hospital), Hidetoshi Igari(Chiba University), Kōichiro Tanaka(Kyoto University), Yoshihito Ozawa(Chiba University Hospital), Masahiko Nezu(Chiba University), Tadashi Ishii(Tohoku University Hospital), Ryutaro Arita(Tohoku University Hospital), Juichi Sato(Nagoya University Hospital), Makoto Arai(Tokyo Metropolitan Institute of Medical Science)
Cited by 17
Related Papers
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
The Tohoku Medical Megabank Project: Design and Mission
|Journal of Epidemiology|2016|386
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart
|Biochemical Journal|1998|310
Nutraceutical Effects of Branched-Chain Amino Acids on Skeletal Muscle
|Journal of Nutrition|2006|294